# Axsome Therapeutics (AXSM): value investors who own it

1 value investor held Axsome Therapeutics in their Q3 2026 13F, led by Polen Capital Management.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Polen Capital Management | 0.0% | $1.1m | Added +111% | 2 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-09-03 | Jacobson Mark L. | Chief Operating Officer | Sold | 10000 | $2.1m |
| 2026-08-06 | TABUTEAU HERRIOT | Chief Executive Officer | Sold | 4660 | $997k |
| 2026-08-05 | TABUTEAU HERRIOT | Chief Executive Officer | Sold | 45004 | $9.5m |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/axsm). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.